BBOTVSNIVF• 28 Days (Normalized)
BBOT vs NIVF (BridgeBio Oncology Therapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.68%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.13
-88.68%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+32 pts
BBOT outperforming by 32.00 percentage points
BBOTNIVF
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BBOT Price | BBOT Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.68% | $0.13 | -88.68% | +32.00% |
| Oct 01, 2026 | $- | $0.10 | -91.14% | - | |
| Sep 30, 2026 | $4.10 | -54.34% | $0.17 | -85.26% | +30.92% |
| Sep 29, 2026 | $3.92 | -56.35% | $0.07 | -93.68% | +37.33% |
| Sep 28, 2026 | $3.81 | -57.57% | $0.35 | -69.74% | +12.17% |
| Sep 25, 2026 | $3.95 | -56.01% | $- | - | |
| Sep 24, 2026 | $3.99 | -55.57% | $- | - | |
| Sep 23, 2026 | $4.16 | -53.67% | $0.59 | -48.25% | -5.42% |
| Sep 22, 2026 | $4.66 | -48.11% | $0.73 | -35.65% | -12.46% |
| Sep 21, 2026 | $4.66 | -48.11% | $0.72 | -36.84% | -11.27% |
| Sep 18, 2026 | $4.77 | -46.88% | $0.72 | -36.93% | -9.95% |
| Sep 17, 2026 | $4.89 | -45.55% | $0.72 | -37.28% | -8.27% |
| Sep 16, 2026 | $4.76 | -46.99% | $0.79 | -31.14% | -15.85% |
| Sep 15, 2026 | $4.88 | -45.66% | $0.84 | -26.32% | -19.34% |
| Sep 14, 2026 | $5.05 | -43.76% | $0.93 | -18.51% | -25.25% |
Page 1 of 2